Time and Theophylline Concentration Help Explain the Recovery of Peak Flow Following Acute Airways Obstruction
暂无分享,去创建一个
[1] M. Chandler,et al. Pulmonary Function in the Elderly: Response to Theophylline Bronchodilation , 1990, Journal of clinical pharmacology.
[2] F. Follath,et al. Theophylline serum concentration and therapeutic effect in severe acute bronchial obstruction: the optimal use of intravenously administered aminophylline. , 1982, American Review of Respiratory Disease.
[3] L. Sheiner,et al. Understanding the Dose-Effect Relationship , 1981, Clinical pharmacokinetics.
[4] M. Aubier,et al. A randomized, controlled trial of theophylline in patients with severe chronic obstructive pulmonary disease. , 1989, The New England journal of medicine.
[5] D. Bates,et al. Nonlinear mixed effects models for repeated measures data. , 1990, Biometrics.
[6] R. Ogilvie,et al. Rational intravenous doses of theophylline. , 1973, The New England journal of medicine.
[7] R Couch,et al. Theophylline Target Concentration in Severe Airways Obstruction — 10 or 20 mg/L? , 1993, Clinical pharmacokinetics.
[8] Carl de Boor,et al. A Practical Guide to Splines , 1978, Applied Mathematical Sciences.
[9] A. Gelb,et al. Aminophylline increases the toxicity but not the efficacy of an inhaled beta-adrenergic agonist in the treatment of acute exacerbations of asthma. , 1985, The American review of respiratory disease.
[10] L. Benet,et al. PREDNISOLONE PHARMACODYNAMICS ASSESSED BY INHIBITION OF THE MIXED LYMPHOCYTE REACTION , 1982, Transplantation.
[11] W. Cleveland. Robust Locally Weighted Regression and Smoothing Scatterplots , 1979 .